Sign in
4

Changes in Ownership

Cytosorbents Corp Filed Acc 0001104659-22-090254

Chief Medical Officer acquired 107,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Deliargyris Efthymios · Chief Medical Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Owned after D/I
2022-08-10 Grant or award : show line 1 in the form +55,000 228,384 D
2022-08-10 Grant or award : show line 2 in the form +52,000 283,384 D

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2022-08-10 Grant or award : show line 3 in the form Stock Option (right to buy) +74,000 74,000 D
2022-08-10 Grant or award : show line 4 in the form Stock Option (right to buy) +300,000 300,000 D
Loading xslF345X03/tm2223355-5_4seq1.xml…